These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 2912432

  • 1. Identification of low density lipoprotein receptor abnormalities by assaying functional receptors on proliferating lymphocytes.
    Cuthbert JA, Lipsky PE.
    Arteriosclerosis; 1989; 9(1 Suppl):I43-9. PubMed ID: 2912432
    [Abstract] [Full Text] [Related]

  • 2. Assessment of functional low-density lipoprotein receptor activity on lymphocytes of normal subjects and patients with familial hypercholesterolemia.
    Cuthbert JA, Lipsky PE.
    Trans Assoc Am Physicians; 1988; 101():1-11. PubMed ID: 3269672
    [Abstract] [Full Text] [Related]

  • 3. Detection of familial hypercholesterolemia by assaying functional low-density-lipoprotein receptors on lymphocytes.
    Cuthbert JA, East CA, Bilheimer DW, Lipsky PE.
    N Engl J Med; 1986 Apr 03; 314(14):879-83. PubMed ID: 3633381
    [Abstract] [Full Text] [Related]

  • 4. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK.
    Dan Med Bull; 2002 Nov 03; 49(4):318-45. PubMed ID: 12553167
    [Abstract] [Full Text] [Related]

  • 5. Regulation of lymphocyte proliferation by cholesterol: the role of endogenous sterol metabolism and low density lipoprotein receptors.
    Cuthbert JA, Lipsky PE.
    Int J Tissue React; 1987 Nov 03; 9(6):447-57. PubMed ID: 3448024
    [Abstract] [Full Text] [Related]

  • 6. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
    Liu YR, Tao QM, Chen JZ, Tao M, Guo XG, Shang YP, Zhu JH, Zhang FR, Zheng LR, Wang XX.
    Sheng Li Xue Bao; 2004 Oct 25; 56(5):566-72. PubMed ID: 15497035
    [Abstract] [Full Text] [Related]

  • 7. Flow cytometric measurement of low density lipoprotein receptor activity validated by DNA analysis in diagnosing heterozygous familial hypercholesterolemia.
    Urdal P, Leren TP, Tonstad S, Lund PK, Ose L.
    Cytometry; 1997 Oct 15; 30(5):264-8. PubMed ID: 9383100
    [Abstract] [Full Text] [Related]

  • 8. [LDL receptors].
    Ducobu J.
    Rev Med Brux; 1990 Dec 15; 11(10):481-92. PubMed ID: 2293288
    [Abstract] [Full Text] [Related]

  • 9. A double mutant [N543H+2393del9] allele in the LDL receptor gene in familial hypercholesterolemia: effect on plasma cholesterol levels and cardiovascular disease.
    Castillo S, Reyes G, Tejedor D, Mozas P, Suarez Y, Lasuncion MA, Cenarro A, Civeira F, Alonso R, Mata P, Pocovi M, Spanish Group of FH.
    Hum Mutat; 2002 Dec 15; 20(6):477. PubMed ID: 12442279
    [Abstract] [Full Text] [Related]

  • 10. Normalization of LDL receptor function by lymphocytes of patients with heterozygous familial hypercholesterolemia after treatment with plasma cholesterol lowering agents.
    Cuthbert JA, East CA, Lipsky PE.
    Am J Med Sci; 1989 Sep 15; 298(3):152-60. PubMed ID: 2552800
    [Abstract] [Full Text] [Related]

  • 11. Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia.
    Pappu AS, Illingworth DR.
    J Lab Clin Med; 1989 Nov 15; 114(5):554-62. PubMed ID: 2809398
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of a lymphocyte surface receptor for low density lipoprotein inhibitor, an immunoregulatory species of normal human serum low density lipoprotein.
    Curtiss LK, Edgington TS.
    J Clin Invest; 1978 May 15; 61(5):1298-308. PubMed ID: 207735
    [Abstract] [Full Text] [Related]

  • 14. Pediatric implications of heterozygous familial hypercholesterolemia. Screening and dietary treatment.
    Kwiterovich PO.
    Arteriosclerosis; 1989 May 15; 9(1 Suppl):I111-20. PubMed ID: 2563219
    [Abstract] [Full Text] [Related]

  • 15. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH, Nguyen LB, Shefer S, Salen G, Batta AK, Frohlich JJ.
    Metabolism; 2001 Jun 15; 50(6):708-14. PubMed ID: 11398149
    [Abstract] [Full Text] [Related]

  • 16. [Study of LDL receptors and response to lovastatin therapy in familial homozygotic hypercholesterolemia].
    Ausina Gómez A, Gilsanz Peral A, Montero Brens C, Dalmau Serra J.
    An Esp Pediatr; 1991 Nov 15; 35(5):327-31. PubMed ID: 1785747
    [Abstract] [Full Text] [Related]

  • 17. Synergistic upregulation of low-density lipoprotein receptor activity by tamoxifen and lovastatin.
    Suárez Y, Fernández C, Gómez-Coronado D, Ferruelo AJ, Dávalos A, Martínez-Botas J, Lasunción MA.
    Cardiovasc Res; 2004 Nov 01; 64(2):346-55. PubMed ID: 15485695
    [Abstract] [Full Text] [Related]

  • 18. The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.
    Rader DJ, Mann WA, Cain W, Kraft HG, Usher D, Zech LA, Hoeg JM, Davignon J, Lupien P, Grossman M.
    J Clin Invest; 1995 Mar 01; 95(3):1403-8. PubMed ID: 7883987
    [Abstract] [Full Text] [Related]

  • 19. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D, Wu B, Li Y, Heng W, Zhong H, Mu Y, Wang J.
    J Hum Genet; 2001 Mar 01; 46(3):152-4. PubMed ID: 11310584
    [Abstract] [Full Text] [Related]

  • 20. Adrenocortical function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin).
    Fojo SS, Hoegg JM, Lackner KJ, Anchors JM, Bailey KR, Brewer HB.
    Horm Metab Res; 1987 Dec 01; 19(12):648-52. PubMed ID: 2831127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.